The Influence of 11+ on Injury Incidence and FMS-Score in Veteran Soccer Players

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01993056

Enrollment

265

Registered

2013-11-25

Start date

2011-08-31

Completion date

2012-06-30

Last updated

2013-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Injury

Keywords

injury incidence, male veteran soccer, 11+, Functional Movement Screen, FMS, warm-up

Brief summary

According to available data the injury rate in male veteran soccer is high. Interventions to prevent injuries are requested. The 11+ warm-up program was developed by FIFA-experts and consists of several exercises with an overall-length of about 20 min. This study shall investigate the influence of 11+ on injury incidence and Functional Movement Screen (FMS)-Score in male veteran soccer players. Additionally it is to be examined if there is a relationship between FMS-Score and injury incidence. For this purpose the 11+-program is accomplished under supervised conditions over one regular season in a randomized-controlled study design. Injuries are documented via questionnaires in accordance with the FIFA-consensus-statement. FMS-Score is evaluated before and after the interventional period.

Interventions

BEHAVIORALFIFA 11+

BEHAVIORALno FIFA 11+

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

MALE

Age

32 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* male veteran soccer players aged 32 and older, who are member of a club veteran team; training and matches on a regular basis

Exclusion criteria

* major time-loss injury, chronic inflammatory joint disease

Design outcomes

Primary

Measure	Time frame	Description
injury incidence	August 2011 - June 2012	injury incidence (injuries per 1000h of soccer)

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026